Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+11.1%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$79B
AUM Growth
+$5.52B
(+7.5%)
Cap. Flow
-$7.71B
Cap. Flow
% of AUM
-9.75%
Top 10 Holdings %
Top 10 Hldgs %
24.46%
Holding
2,612
New
284
Increased
737
Reduced
832
Closed
260
Top Buys
| 1 |
Chubb
CB
|
+$574M |
| 2 |
American Electric Power
AEP
|
+$284M |
| 3 |
Ulta Beauty
ULTA
|
+$187M |
| 4 |
CVS Health
CVS
|
+$177M |
| 5 |
McDonald's
MCD
|
+$151M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$422M |
| 2 |
Johnson & Johnson
JNJ
|
+$213M |
| 3 |
Aon
AON
|
+$192M |
| 4 |
Norfolk Southern
NSC
|
+$183M |
| 5 |
CyberArk
CYBR
|
+$168M |
Sector Composition
| 1 | Technology | 20.99% |
| 2 | Financials | 14.11% |
| 3 | Healthcare | 13.38% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Insight Enterprises
NSIT
$4.07B
| $73K | ﹤0.01% |
+417
| New | +$73K |
|
1602
Teladoc Health
TDOC
$1.37B
| $73K | ﹤0.01% |
3,431
+232
| +7% | +$4.94K |
|
|
XHR
1603
Xenia Hotels & Resorts
XHR
$1.41B
| $73K | ﹤0.01% |
5,392
| – | – |
|
|
CHS
1604
DELISTED
Chicos FAS, Inc.
CHS
| $73K | ﹤0.01% |
9,680
+26
| +0.3% | +$196 |
|
1605
Columbia Banking Systems
COLB
$7.87B
| $72K | ﹤0.01% |
2,731
-93
| -3% | -$2.45K |
|
1606
Simply Good Foods
SMPL
$2.78B
| $72K | ﹤0.01% |
+1,819
| New | +$72K |
|
1607
Shutterstock
SSTK
$750M
| $72K | ﹤0.01% |
1,511
+123
| +9% | +$5.86K |
|
|
ITCI
1608
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $71K | ﹤0.01% |
997
| – | – |
|
1609
Aehr Test Systems
AEHR
$795M
| $70K | ﹤0.01% |
+2,699
| New | +$70K |
|
1610
Ardmore Shipping
ASC
$502M
| $70K | ﹤0.01% |
+5,003
| New | +$70K |
|
|
CMRC
1611
Commerce.com, Inc. Series 1 Common Stock
CMRC
$376M
| $70K | ﹤0.01% |
7,237
-276
| -4% | -$2.67K |
|
1612
Peabody Energy
BTU
$2.25B
| $70K | ﹤0.01% |
+2,911
| New | +$70K |
|
1613
Genpact
G
$7.55B
| $70K | ﹤0.01% |
2,023
+364
| +22% | +$12.6K |
|
1614
NOV
NOV
$4.94B
| $70K | ﹤0.01% |
+3,489
| New | +$70K |
|
1615
Roku
ROKU
$14.2B
| $70K | ﹤0.01% |
768
+568
| +284% | +$51.8K |
|
1616
Semrush
SEMR
$1.13B
| $70K | ﹤0.01% |
5,187
+302
| +6% | +$4.08K |
|
1617
Williams Companies
WMB
$72.5B
| $70K | ﹤0.01% |
2,014
+13
| +0.6% | +$452 |
|
|
ENZ
1618
DELISTED
Enzo Biochem, Inc.
ENZ
| $70K | ﹤0.01% |
50,453
| – | – |
|
1619
C4 Therapeutics
CCCC
$194M
| $69K | ﹤0.01% |
+12,375
| New | +$69K |
|
1620
Vaalco Energy
EGY
$417M
| $69K | ﹤0.01% |
15,467
-8,892
| -37% | -$39.7K |
|
1621
EQT Corp
EQT
$31.8B
| $69K | ﹤0.01% |
1,797
-211,195
| -99% | -$8.11M |
|
1622
Churchill Downs
CHDN
$6.93B
| $68K | ﹤0.01% |
+504
| New | +$68K |
|
1623
DHT Holdings
DHT
$1.99B
| $68K | ﹤0.01% |
6,973
-50,584
| -88% | -$493K |
|
1624
Future Fuel
FF
$172M
| $68K | ﹤0.01% |
11,293
+11,055
| +4,645% | +$66.6K |
|
1625
Noble Corp
NE
$4.85B
| $68K | ﹤0.01% |
+1,429
| New | +$68K |
|